GSK launched a 2 billion pounds ($2.5 billion) share buyback on Wednesday and lifted its long-term sales target to nearly $50 ...
The pharmaceutical giant's revenue jumped 21 per cent last year despite growing troubles over its presence in China, where it ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback